Author

Hui Zhao

Agilent Technologies (United States)ORCID 0000-0002-9221-6831Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hui Zhao4 papers · Air Force Medical University

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:bacteria (other)· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexandria Taber· 1 shared Amanda Randolph· 1 shared Anissa Martinez· 1 shared Ashley Krzeszowski· 1 shared Baatar MunkhtsetsegiD· 1 shared Benjamin W. JesteriD· 1 shared Brian FinrowiD· 1 shared Brittney Robinett· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alexandria Taber

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Rapid Determination of Drug-to-Antibody Ratios in Antibody Drug Conjugates Using Ultrafast Microdroplet Digestion Technology

Yongqing Yang, Juana Perez Sancheza, Timothy Yaroshuk, M. Hassan, Praneeth Ivan Joel Fnu, Thomas Walker, Jim Lau, Mike Knierman, Hui Zhao, Xi Qiu, Karen Yao Luo, Harsha P. Gunawardena, Baatar Munkhtsetseg, Hao Chen

This paper introduces an ultrafast microdroplet digestion-mass spectrometry method for rapid and accurate determination of drug-to-antibody ratios in ADCs.

bioRxiv · Jun 5, 2026 · PreprintBiochemistry

Expression and Manufacturing of Protein Therapeutics in Spirulina

Benjamin W. Jester, Hui Zhao, Mesfin M. Gewe, Thomas Adame, Lisa Perruzza, David T. Bolick, Jan M. Agosti, Nhi Khuong, Rolf E. Kuestner, Caitlin Gamble, Kendra Cruickshank, Jeremy Ferrara, Rachelle Lim, Troy Paddock, Colin Brady, , James M. Roberts

This paper develops a genetic engineering platform in spirulina for producing bioactive protein therapeutics at scale, demonstrating its potential for low-cost biopharmaceutical manufacturing.

bioRxiv · Jan 25, 2021 · PreprintMolecular Biology